Filter
1125
Text search:
medicines
quality
assurance
Featured
135
408
Language
Document type
671
157
130
65
65
15
9
8
4
1
Countries / Regions
60
54
48
42
33
33
31
29
29
28
27
26
25
24
24
23
20
18
15
12
12
10
10
10
9
8
8
7
7
7
6
6
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
584
103
57
43
32
29
14
2
1
1
Toolboxes
95
87
86
75
33
29
23
20
16
13
12
12
10
10
10
5
5
4
4
2
1
1
1
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Le présent document qui fait suite à la recommandation ci-dessus citées se veut une
traduction de l’objectif n°4 du Plan National de Développement Sanitaire (PNDS)3
. Il
traduit la volonté du gouvernement burkinabé de développer un cadre de référence
pour tout intervenant dans le dom
...
Annex 5, WHO Technical Report Series 1010, 2018
Guidance for the preparation and submission of dossiers
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Malawi Health Sector Strategic Plan 2011 - 2016
recommended
Moving towards equity and quality
